Related Experiment Video
Updated: Aug 27, 2025
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Zhibin Yan1, Xurui Cheng1, Tao Wang1
1Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang 310018, PR China.
Abstract:
Annexin A1, a well-known endogenous anti-inflammatory mediator, plays a critical role in a variety of pathological processes. Fibrosis is described by a failure of tissue regeneration and contributes to the development of many diseases. Accumulating evidence supports that Annexin A1 participates in the progression of tissue fibrosis. However, the fundamental mechanisms by which Annexin A1 regulates fibrosis remain elusive, and even the functions of Annexin A1 in fibrotic diseases are still paradoxical. This review focuses on the roles of Annexin A1 in the development of fibrosis of lung, liver, heart, and other tissues, with emphasis on the therapy potential of Annexin A1 in fibrosis, and presents future research interests and directions in fibrotic diseases.
Insights
Annexin A1, an anti-inflammatory mediator, is implicated in tissue fibrosis. This review explores its paradoxical roles and therapeutic potential in fibrotic diseases like lung, liver, and heart fibrosis.
Area of Science:
- Biomedical Science
- Molecular Biology
- Pathology
Background:
- Annexin A1 is an endogenous anti-inflammatory mediator.
- Fibrosis, characterized by failed tissue regeneration, contributes to numerous diseases.
- Annexin A1 is increasingly recognized for its involvement in fibrosis progression.
Purpose of the Study:
- To review the multifaceted roles of Annexin A1 in the development of fibrosis.
- To explore the therapeutic potential of Annexin A1 in treating fibrotic diseases.
- To identify future research directions in Annexin A1 and fibrosis.
Main Methods:
- Literature review of studies on Annexin A1 and fibrosis.
- Analysis of Annexin A1's mechanisms in various fibrotic tissues (lung, liver, heart).
- Evaluation of Annexin A1-targeted therapies for fibrosis.
Main Results:
- Annexin A1 exhibits complex and sometimes paradoxical functions in fibrotic processes.
- Evidence links Annexin A1 to the progression of fibrosis in multiple organs.
- Annexin A1 modulation presents potential therapeutic strategies for fibrotic conditions.
Conclusions:
- Understanding Annexin A1's precise mechanisms in fibrosis is crucial.
- Targeting Annexin A1 may offer novel therapeutic avenues for fibrotic diseases.
- Further research is needed to fully elucidate Annexin A1's role and therapeutic utility.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...